Published in Am J Pathol on June 01, 2006
Glypican-1 identifies cancer exosomes and detects early pancreatic cancer. Nature (2015) 5.15
Proteoglycans in cancer biology, tumour microenvironment and angiogenesis. J Cell Mol Med (2011) 2.21
Chemical Tumor Biology of Heparan Sulfate Proteoglycans. Curr Chem Biol (2010) 1.17
NFAT promotes carcinoma invasive migration through glypican-6. Biochem J (2011) 1.09
Signal transducers and activators of transcription mediate fibroblast growth factor-induced vascular endothelial morphogenesis. Cancer Res (2009) 1.04
A novel mechanism of sequestering fibroblast growth factor 2 by glypican in lipid rafts, allowing skeletal muscle differentiation. Mol Cell Biol (2010) 1.00
Proteoglycans and their roles in brain cancer. FEBS J (2013) 0.98
Intracerebral chondroitinase ABC and heparan sulfate proteoglycan glypican improve outcome from chronic stroke in rats. Proc Natl Acad Sci U S A (2012) 0.98
Retracted Glypican-1 stimulates Skp2 autoinduction loop and G1/S transition in endothelial cells. J Biol Chem (2011) 0.93
microRNA-100 targets SMRT/NCOR2, reduces proliferation, and improves survival in glioblastoma animal models. PLoS One (2013) 0.92
Autoregulation of glypican-1 by intronic microRNA-149 fine tunes the angiogenic response to FGF2 in human endothelial cells. J Cell Sci (2014) 0.87
Glypican-1 regulates anaphase promoting complex/cyclosome substrates and cell cycle progression in endothelial cells. Mol Biol Cell (2008) 0.87
Altering Glypican-1 levels modulates canonical Wnt signaling during trigeminal placode development. Dev Biol (2010) 0.84
Heparan sulfate proteoglycans and human breast cancer epithelial cell tumorigenicity. J Cell Biochem (2014) 0.82
Retracted Glypican 1 stimulates S phase entry and DNA replication in human glioma cells and normal astrocytes. Mol Cell Biol (2013) 0.81
Novel therapeutic targets in the brain tumor microenvironment. Oncotarget (2012) 0.81
Sugar glues for broken neurons. Biomol Concepts (2013) 0.78
Proteoglycans: master modulators of paracrine fibroblast-carcinoma cell interactions. Semin Cell Dev Biol (2009) 0.78
Caudatin Inhibits Human Glioma Cells Growth Through Triggering DNA Damage-Mediated Cell Cycle Arrest. Cell Mol Neurobiol (2015) 0.78
Extracellular Matrix Glycoprotein-Derived Synthetic Peptides Differentially Modulate Glioma and Sarcoma Cell Migration. Cell Mol Neurobiol (2015) 0.77
Secreted primary human malignant mesothelioma exosome signature reflects oncogenic cargo. Sci Rep (2016) 0.77
Brain heparan sulphate proteoglycans are altered in developing foetus when exposed to in-utero hyperglycaemia. Metab Brain Dis (2017) 0.77
Heparan sulfate proteoglycans undergo differential expression alterations in right sided colorectal cancer, depending on their metastatic character. BMC Cancer (2015) 0.75
Overexpression of glypican-1 implicates poor prognosis and their chemoresistance in oesophageal squamous cell carcinoma. Br J Cancer (2016) 0.75
Structural Aspects of N-Glycosylations and the C-terminal Region in Human Glypican-1. J Biol Chem (2015) 0.75
Glypican-1 in exosomes as biomarker for early detection of pancreatic cancer. Ann Transl Med (2016) 0.75
α3 Chains of type V collagen regulate breast tumour growth via glypican-1. Nat Commun (2017) 0.75
Diagnostic and prognostic significance of glypican 5 and glypican 6 gene expression levels in gastric adenocarcinoma. Mol Clin Oncol (2015) 0.75
GPC1 exosome and its regulatory miRNAs are specific markers for the detection and target therapy of colorectal cancer. J Cell Mol Med (2017) 0.75
Characterization of Heparan Sulfate Proteoglycan-positive Recycling Endosomes Isolated from Glioma Cells. Cancer Genomics Proteomics (2016) 0.75
Estrogen receptor status by immunohistochemistry is superior to the ligand-binding assay for predicting response to adjuvant endocrine therapy in breast cancer. J Clin Oncol (1999) 11.18
Receptor specificity of the fibroblast growth factor family. J Biol Chem (1996) 7.58
Crystal structure of a ternary FGF-FGFR-heparin complex reveals a dual role for heparin in FGFR binding and dimerization. Mol Cell (2000) 5.72
Crystal structure of fibroblast growth factor receptor ectodomain bound to ligand and heparin. Nature (2000) 3.90
Heparin is required for cell-free binding of basic fibroblast growth factor to a soluble receptor and for mitogenesis in whole cells. Mol Cell Biol (1992) 3.41
Roles of heparan-sulphate glycosaminoglycans in cancer. Nat Rev Cancer (2002) 3.36
Structural insights into biological roles of protein-glycosaminoglycan interactions. Chem Biol (2005) 2.67
Heparan sulfate: decoding a dynamic multifunctional cell regulator. Trends Cell Biol (2001) 2.67
Developmental changes in heparan sulfate expression: in situ detection with mAbs. J Cell Biol (1992) 2.61
Dally cooperates with Drosophila Frizzled 2 to transduce Wingless signalling. Nature (1999) 2.53
Loss of HSulf-1 up-regulates heparin-binding growth factor signaling in cancer. J Biol Chem (2003) 2.40
The cell-surface heparan sulfate proteoglycan glypican-1 regulates growth factor action in pancreatic carcinoma cells and is overexpressed in human pancreatic cancer. J Clin Invest (1998) 2.22
Heparan sulfate oligosaccharides require 6-O-sulfation for promotion of basic fibroblast growth factor mitogenic activity. J Biol Chem (1998) 1.97
Glypicans in growth control and cancer. Glycobiology (2001) 1.75
HSulf-1 and HSulf-2 are potent inhibitors of myeloma tumor growth in vivo. J Biol Chem (2005) 1.66
Immunohistochemical localization of basic fibroblast growth factor in astrocytomas. Cancer Res (1990) 1.59
Glypican-1 is overexpressed in human breast cancer and modulates the mitogenic effects of multiple heparin-binding growth factors in breast cancer cells. Cancer Res (2001) 1.55
Molecular cloning of amphiglycan, a novel integral membrane heparan sulfate proteoglycan expressed by epithelial and fibroblastic cells. J Cell Biol (1992) 1.51
Microdetermination of proteoglycans and glycosaminoglycans in the presence of guanidine hydrochloride. Anal Biochem (1987) 1.43
Gene expression of fibroblast growth factors in human gliomas and meningiomas: demonstration of cellular source of basic fibroblast growth factor mRNA and peptide in tumor tissues. Proc Natl Acad Sci U S A (1990) 1.41
The autocrine loop of TGF-alpha/EGFR and brain tumors. J Neurooncol (1997) 1.40
Differential expression of two fibroblast growth factor-receptor genes is associated with malignant progression in human astrocytomas. Proc Natl Acad Sci U S A (1994) 1.39
Stimulation of fibroblast growth factor receptor-1 occupancy and signaling by cell surface-associated syndecans and glypican. J Cell Biol (1996) 1.35
Structural specificity of heparin binding in the fibroblast growth factor family of proteins. Proc Natl Acad Sci U S A (2003) 1.34
The role of glypicans in mammalian development. Biochim Biophys Acta (2002) 1.33
Selectively desulfated heparin inhibits fibroblast growth factor-induced mitogenicity and angiogenesis. J Biol Chem (2000) 1.31
OCI-5/rat glypican-3 binds to fibroblast growth factor-2 but not to insulin-like growth factor-2. J Biol Chem (1997) 1.28
Composition and distribution of glycosaminoglycans in cultures of human normal and malignant glial cells. Biochem J (1978) 1.15
Quantitation of proteoglycans in biological fluids using Alcian blue. Methods Mol Biol (2001) 1.13
Role of heparan sulfate as a tissue-specific regulator of FGF-4 and FGF receptor recognition. J Cell Biol (2001) 1.12
Mechanisms underlying preferential assembly of heparan sulfate on glypican-1. J Biol Chem (2000) 1.11
Heparan sulfate proteoglycans as regulators of fibroblast growth factor-2 receptor binding in breast carcinomas. Am J Pathol (2002) 1.05
Heparan sulfate proteoglycans as regulators of fibroblast growth factor-2 signaling in brain endothelial cells. Specific role for glypican-1 in glioma angiogenesis. J Biol Chem (2003) 1.02
Altered expression and distribution of heparan sulfate proteoglycans in human gliomas. Cancer Res (1989) 1.02
Identification of the motif in versican G3 domain that plays a dominant-negative effect on astrocytoma cell proliferation through inhibiting versican secretion and binding. J Biol Chem (2001) 1.00
Suppression of invasive behavior of melanoma cells by stable expression of anti-sense perlecan cDNA. Ann Oncol (1997) 0.94
Mitogenic signaling cascades in glial tumors. Neurosurgery (2003) 0.93
Dermatan sulfate proteoglycan and glycosaminoglycan synthesis is induced in fibroblasts by transfer to a three-dimensional extracellular environment. J Biol Chem (2004) 0.88
Importance of 2-O-sulfate groups of uronate residues in heparin for activation of FGF-1 and FGF-2. J Biochem (1997) 0.88
Increased expression of genes from growth factor signaling pathways in glioblastoma cell lines. Oncogene (1992) 0.85
Fibroblast growth factor-2 can mediate cell attachment by linking receptors and heparan sulfate proteoglycans on neighboring cells. J Biol Chem (1995) 0.85
Heparan sulphate sulphotransferase expression in mice and Caenorhabditis elegans. Biochem Soc Trans (2003) 0.84
Epidermal growth factor and pro-inflammatory cytokines regulate the expression of components of plasminogen activation system in U373-MG astrocytoma cells. Cytokine (2001) 0.84
Basic fibroblast growth factor: a potential autocrine regulator of human glioma cell growth. J Neurosci Res (1990) 0.83
Turnover of cell surface associated glycosaminoglycans in cultures of human normal and malignant glial cells. Exp Cell Res (1978) 0.80
Induction of apoptosis in glioma cells: an approach to control tumor growth by blocking basic fibroblast growth factor autocrine loop. Anticancer Res (2000) 0.77
Aligned collagen is a prognostic signature for survival in human breast carcinoma. Am J Pathol (2011) 3.70
Campath-1H induction plus rapamycin monotherapy for renal transplantation: results of a pilot study. Am J Transplant (2003) 2.83
FAN1 mutations cause karyomegalic interstitial nephritis, linking chronic kidney failure to defective DNA damage repair. Nat Genet (2012) 2.74
Mitochondrial DNA-deletion mutations accumulate intracellularly to detrimental levels in aged human skeletal muscle fibers. Am J Hum Genet (2006) 2.43
Neutrophil gelatinase-associated lipocalin (NGAL) is a predictor of poor prognosis in human primary breast cancer. Breast Cancer Res Treat (2007) 1.85
HSulf-1 inhibits angiogenesis and tumorigenesis in vivo. Cancer Res (2006) 1.71
Transition to invasion in breast cancer: a microfluidic in vitro model enables examination of spatial and temporal effects. Integr Biol (Camb) (2010) 1.41
Isoform-specific expression of 14-3-3 proteins in human lung cancer tissues. Int J Cancer (2005) 1.37
Control of 3-dimensional collagen matrix polymerization for reproducible human mammary fibroblast cell culture in microfluidic devices. Biomaterials (2009) 1.37
Shedding of syndecan-1 by stromal fibroblasts stimulates human breast cancer cell proliferation via FGF2 activation. J Biol Chem (2007) 1.35
Phase I pharmacokinetic and pharmacodynamic study of recombinant human endostatin in patients with advanced solid tumors. J Clin Oncol (2003) 1.33
Phase I trial of a monoclonal antibody specific for alphavbeta3 integrin (MEDI-522) in patients with advanced malignancies, including an assessment of effect on tumor perfusion. Clin Cancer Res (2005) 1.23
Induction of syndecan-1 expression in stromal fibroblasts promotes proliferation of human breast cancer cells. Cancer Res (2004) 1.18
The transcription factor REST is lost in aggressive breast cancer. PLoS Genet (2010) 1.17
Syndecan-1 and syndecan-4 are overexpressed in an estrogen receptor-negative, highly proliferative breast carcinoma subtype. Breast Cancer Res Treat (2006) 1.14
Syndecan-1 in breast cancer stroma fibroblasts regulates extracellular matrix fiber organization and carcinoma cell motility. Am J Pathol (2010) 1.13
3D microchannel co-culture: method and biological validation. Integr Biol (Camb) (2010) 1.13
Heparan sulfate proteoglycans as regulators of fibroblast growth factor-2 receptor binding in breast carcinomas. Am J Pathol (2002) 1.05
Understanding the impact of 2D and 3D fibroblast cultures on in vitro breast cancer models. PLoS One (2013) 1.04
Signal transducers and activators of transcription mediate fibroblast growth factor-induced vascular endothelial morphogenesis. Cancer Res (2009) 1.04
Heparan sulfate proteoglycans as regulators of fibroblast growth factor-2 signaling in brain endothelial cells. Specific role for glypican-1 in glioma angiogenesis. J Biol Chem (2003) 1.02
Lack of association between EBV and breast carcinoma. Cancer Epidemiol Biomarkers Prev (2005) 1.02
Membrane type 1 matrix metalloproteinase-mediated stromal syndecan-1 shedding stimulates breast carcinoma cell proliferation. Cancer Res (2008) 1.00
Alterations in the p16/pRb cell cycle checkpoint occur commonly in primary and metastatic human prostate cancer. Cancer Lett (2002) 0.99
Syndecan-1 accumulates in lysosomes of poorly differentiated breast carcinoma cells. Matrix Biol (2003) 0.95
Retracted Glypican-1 stimulates Skp2 autoinduction loop and G1/S transition in endothelial cells. J Biol Chem (2011) 0.93
Correlation between human leukocyte antigen antibody production and serum creatinine in patients receiving sirolimus monotherapy after Campath-1H induction. Transplantation (2004) 0.92
Regulation of fibroblast growth factor-2 activity by human ovarian cancer tumor endothelium. Clin Cancer Res (2005) 0.92
Functional screen of paracrine signals in breast carcinoma fibroblasts. PLoS One (2012) 0.91
Colorectal cancer desmoplastic reaction up-regulates collagen synthesis and restricts cancer cell invasion. Cell Tissue Res (2011) 0.91
A case series of primary central nervous system posttransplantation lymphoproliferative disorder: imaging and clinical characteristics. Neurosurgery (2013) 0.90
Caffeine induces TP53-independent G(1)-phase arrest and apoptosis in human lung tumor cells in a dose-dependent manner. Radiat Res (2002) 0.90
Karyomegalic tubulointerstitial nephritis--a case report. Pathol Res Pract (2006) 0.89
Effects of a monoclonal anti-alphavbeta3 integrin antibody on blood vessels - a pharmacodynamic study. Invest New Drugs (2006) 0.89
STAT5 and prolactin participate in a positive autocrine feedback loop that promotes angiogenesis. J Biol Chem (2013) 0.87
Glypican-1 regulates anaphase promoting complex/cyclosome substrates and cell cycle progression in endothelial cells. Mol Biol Cell (2008) 0.87
Colonic adenocarcinoma in a 13-year-old with cystic fibrosis. J Pediatr Surg (2007) 0.86
Organ weight changes associated with body mass index determined from a medical autopsy population. Am J Forensic Med Pathol (2012) 0.82
Stimulation of glucose uptake by Musa sp. (cv. elakki bale) flower and pseudostem extracts in Ehrlich ascites tumor cells. J Sci Food Agric (2011) 0.81
Retracted Glypican 1 stimulates S phase entry and DNA replication in human glioma cells and normal astrocytes. Mol Cell Biol (2013) 0.81
p16 Is upregulated in proliferative inflammatory atrophy of the prostate. Prostate (2005) 0.81
A positive feedback loop between prolactin and STAT5 promotes angiogenesis. Adv Exp Med Biol (2015) 0.79
Normal mammary fibroblasts induce reversion of the malignant phenotype in human primary breast cancer. Anticancer Res (2013) 0.79
Structure of pleiotrophin- and hepatocyte growth factor-binding sulfated hexasaccharide determined by biochemical and computational approaches. J Biol Chem (2010) 0.79
Intracranial blastomycosis presenting as an enhancing cerebellopontine mass. Turk Neurosurg (2013) 0.78
The subparietal and parietooccipital sulci: an anatomical study. Clin Anat (2013) 0.77
Induction of the RNA regulator LIN28A is required for the growth and pathogenesis of RESTless breast tumors. Cancer Res (2012) 0.77
Structural characterization of N-linked oligosaccharides of laminin from rat kidney: changes during diabetes and modulation by dietary fiber and butyric acid. FEBS J (2010) 0.77
Angiogenesis induced by signal transducer and activator of transcription 5A (STAT5A) is dependent on autocrine activity of proliferin. J Biol Chem (2011) 0.77
Atypical meningioma: randomized trials are required to resolve contradictory retrospective results regarding the role of adjuvant radiotherapy. J Cancer Res Ther (2015) 0.77
Oncogenic Kras expression in postmitotic neurons leads to S100A8-S100A9 protein overexpression and gliosis. J Biol Chem (2012) 0.76
Heparan sulphate proteoglycan in scleromyxedema promotes FGF-2 activity. Pathol Res Pract (2002) 0.76
Mammary fibroblasts regulate morphogenesis of normal and tumorigenic breast epithelial cells by mechanical and paracrine signals. Cancer Lett (2012) 0.76
Motor neuron disease with selective degeneration of anterior horn cells associated with non-Hodgkin lymphoma. J Clin Neuromuscul Dis (2014) 0.75
The determination and comparison of the vascular configurations of the posterior cerebral and posterior communicating arteries by two different techniques. J Neurosurg Sci (2014) 0.75
Microsurgical anatomy of the posterior median septum of the human spinal cord. Clin Anat (2014) 0.75
Distraction osteogenesis-induced muscle fibrosis may not be associated with TGF-β1. J Pediatr Orthop (2011) 0.75
Glypican-1 stimulates Skp2 autoinduction loop and G1/S transition in endothelial cells. J Biol Chem (2016) 0.75
Epithelial cell polarity and improved early outcomes in delayed graft function: a pilot study of polyclonal vs monoclonal antibodies. Nephrol Dial Transplant (2004) 0.75